A review revealed in JAMA Community Open up emphasizes the discrepancy between what it fees to provide copyright along with the retail costs sufferers deal with. Regardless of the very low manufacturing prices, Novo Nordisk hasn't publicly disclosed specific figures for copyright or its other product or service, Wegovy.In Oct 2024, Novo Nordisk rev